Cargando…
Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure
Acute Liver Failure (ALF) is a life-threatening illness characterized by the rapid onset of abnormal liver biochemistries, coagulopathy, and the development of hepatic encephalopathy. Extracorporeal bioengineered liver (BEL) grafts could offer a bridge therapy to transplant or recovery. The present...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604724/ https://www.ncbi.nlm.nih.gov/pubmed/37892931 http://dx.doi.org/10.3390/bioengineering10101201 |
_version_ | 1785126903947984896 |
---|---|
author | Nelson, Victoria L. Stumbras, Aron R. Palumbo, R. Noelle Riesgraf, Shawn A. Balboa, Marie S. Hannah, Zachary A. Bergstrom, Isaac J. Fecteau, Christopher J. Lake, John R. Barry, John J. Ross, Jeff J. |
author_facet | Nelson, Victoria L. Stumbras, Aron R. Palumbo, R. Noelle Riesgraf, Shawn A. Balboa, Marie S. Hannah, Zachary A. Bergstrom, Isaac J. Fecteau, Christopher J. Lake, John R. Barry, John J. Ross, Jeff J. |
author_sort | Nelson, Victoria L. |
collection | PubMed |
description | Acute Liver Failure (ALF) is a life-threatening illness characterized by the rapid onset of abnormal liver biochemistries, coagulopathy, and the development of hepatic encephalopathy. Extracorporeal bioengineered liver (BEL) grafts could offer a bridge therapy to transplant or recovery. The present study describes the manufacture of clinical scale BELs created from decellularized porcine-derived liver extracellular matrix seeded entirely with human cells: human umbilical vein endothelial cells (HUVECs) and primary human liver cells (PHLCs). Decellularized scaffolds seeded entirely with human cells were shown to adhere to stringent sterility and safety guidelines and demonstrated increased functionality when compared to grafts seeded with primary porcine liver cells (PPLCs). BELs with PHLCs were able to clear more ammonia than PPLCs and demonstrated lower perfusion pressures during patency testing. Additionally, to determine the full therapeutic potential of BELs seeded with PHLCs, longer culture periods were assessed to address the logistical constraints associated with manufacturing and transporting a product to a patient. The fully humanized BELs were able to retain their function after cold storage simulating a product transport period. Therefore, this study demonstrates the manufacture of bioengineered liver grafts and their potential in the clinical setting as a treatment for ALF. |
format | Online Article Text |
id | pubmed-10604724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106047242023-10-28 Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure Nelson, Victoria L. Stumbras, Aron R. Palumbo, R. Noelle Riesgraf, Shawn A. Balboa, Marie S. Hannah, Zachary A. Bergstrom, Isaac J. Fecteau, Christopher J. Lake, John R. Barry, John J. Ross, Jeff J. Bioengineering (Basel) Article Acute Liver Failure (ALF) is a life-threatening illness characterized by the rapid onset of abnormal liver biochemistries, coagulopathy, and the development of hepatic encephalopathy. Extracorporeal bioengineered liver (BEL) grafts could offer a bridge therapy to transplant or recovery. The present study describes the manufacture of clinical scale BELs created from decellularized porcine-derived liver extracellular matrix seeded entirely with human cells: human umbilical vein endothelial cells (HUVECs) and primary human liver cells (PHLCs). Decellularized scaffolds seeded entirely with human cells were shown to adhere to stringent sterility and safety guidelines and demonstrated increased functionality when compared to grafts seeded with primary porcine liver cells (PPLCs). BELs with PHLCs were able to clear more ammonia than PPLCs and demonstrated lower perfusion pressures during patency testing. Additionally, to determine the full therapeutic potential of BELs seeded with PHLCs, longer culture periods were assessed to address the logistical constraints associated with manufacturing and transporting a product to a patient. The fully humanized BELs were able to retain their function after cold storage simulating a product transport period. Therefore, this study demonstrates the manufacture of bioengineered liver grafts and their potential in the clinical setting as a treatment for ALF. MDPI 2023-10-16 /pmc/articles/PMC10604724/ /pubmed/37892931 http://dx.doi.org/10.3390/bioengineering10101201 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nelson, Victoria L. Stumbras, Aron R. Palumbo, R. Noelle Riesgraf, Shawn A. Balboa, Marie S. Hannah, Zachary A. Bergstrom, Isaac J. Fecteau, Christopher J. Lake, John R. Barry, John J. Ross, Jeff J. Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure |
title | Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure |
title_full | Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure |
title_fullStr | Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure |
title_full_unstemmed | Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure |
title_short | Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure |
title_sort | manufacturing and functional characterization of bioengineered liver grafts for extracorporeal liver assistance in acute liver failure |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604724/ https://www.ncbi.nlm.nih.gov/pubmed/37892931 http://dx.doi.org/10.3390/bioengineering10101201 |
work_keys_str_mv | AT nelsonvictorial manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT stumbrasaronr manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT palumbornoelle manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT riesgrafshawna manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT balboamaries manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT hannahzacharya manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT bergstromisaacj manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT fecteauchristopherj manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT lakejohnr manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT barryjohnj manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure AT rossjeffj manufacturingandfunctionalcharacterizationofbioengineeredlivergraftsforextracorporealliverassistanceinacuteliverfailure |